A comparative study of how the healthcare systems of the United States and the United Kingdom shape type I diabetes outcomes

This comparative analysis explores the management of type 1 diabetes within the healthcare systems of the United States and the United Kingdom, highlighting the challenges faced by individuals in both countries despite their differing healthcare models. The United States employs a privatized, insurance-based system, while the United Kingdom operates under a government-funded National Health Service (NHS). This paper examines the accessibility of care, management of Hemoglobin A1C levels, and the disparities faced by ethnic and socioeconomic groups in both countries. Despite the contrasting healthcare structures, both nations exhibit similar negative outcomes in type 1 diabetes management, with significant inequalities affecting poorer communities and minority groups. These groups tend to have higher average HbA1C levels and less access to essential diabetes care, exacerbated by systemic issues such as insurance coverage gaps in the U.S. and long wait times and decentralized funding in the U.K. The findings underscore the need for systemic reforms to provide equitable access and effective diabetes management for all individuals.